8) Kanazawa I, Inaba M, Inoue D, Uenishi K, Saito M, Shiraki M, Suzuki A, Takeuchi Y, Hagino H, Fujiwara S, Sugimoto T, from the Japan Osteoporosis Society Lifestyle diseases-related Fracture Risk Investigation Committee. Executive summary of Clinical Practice Guide on fracture risk in lifestyle diseases. Journal of Bone Mineral Metabolism, 2020; 38(6): 746-758.

---

7) Kanazawa I, Sugimoto T. Diabetes mellitus-induced bone fragility. Internal Medicine, 2018; 57(19): 2773-2785.

---

6) Kanazawa I, Sugimoto T. The mechanism of bone fragility in diabetes mellitus. Glycative Stress Research, 2017; 4(4): 266-274.

---

5) Kanazawa I. Interaction between bone and glucose metabolism. Endocrine Journal, 2017; 64(11): 1043-1053.

---

4) Kanazawa I. Association of the roles of advanced glycation end products and osteocalcin between bone metabolism and vascular failure. Vascular Failure 2017; 1(1): 30-38.

---

3) Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World Journal of Diabetes 2015; 6(18): 1345-1354.

---

2) Kanazawa I. Adiponectin in metabolic bone disease. Current Medicinal Chemistry 2012; 19(32): 5481-5491.

---

1) Kanazawa I. The role of adipokines in bone homeostasis. Adipobiology 2011; 3: 37-48.